333 related articles for article (PubMed ID: 19210109)
1. Esomeprazole: a proton pump inhibitor.
Vachhani R; Olds G; Velanovich V
Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):15-27. PubMed ID: 19210109
[TBL] [Abstract][Full Text] [Related]
2. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.
McKeage K; Blick SK; Croxtall JD; Lyseng-Williamson KA; Keating GM
Drugs; 2008; 68(11):1571-607. PubMed ID: 18627213
[TBL] [Abstract][Full Text] [Related]
3. Esomeprazole for asthma.
Wise MP; Saayman AG; Frost PJ
N Engl J Med; 2009 Jul; 361(2):207; author reply 207-8. PubMed ID: 19593856
[No Abstract] [Full Text] [Related]
4. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.
Pallotta S; Pace F; Marelli S
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):509-22. PubMed ID: 19072398
[TBL] [Abstract][Full Text] [Related]
5. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
Devault KR
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
[TBL] [Abstract][Full Text] [Related]
6. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
[TBL] [Abstract][Full Text] [Related]
7. Phase I, multicenter, randomized, open-label study evaluating the pharmacokinetics and safety profile of repeated once-daily doses of intravenous esomeprazole in children 0 to 17 years of age.
Sandström M; Davidson G; Tolia V; Sullivan JE; Långström G; Lundborg P; Brown K
Clin Ther; 2012 Aug; 34(8):1828-38. PubMed ID: 22832034
[TBL] [Abstract][Full Text] [Related]
8. Potential options to optimize therapy of gastroesophageal reflux disease with proton pump inhibitors.
Tonini M; Vigneri S; Neri M; Cuomo R; Savarino V; Pace F
Digestion; 2007; 76(3-4):171-8. PubMed ID: 18046084
[TBL] [Abstract][Full Text] [Related]
9. [Proton pump inhibitor in the management of acid-related disorders in Japan: history and perspective].
Sugano K
Nihon Rinsho; 2007 Dec; 65(12):2375-81. PubMed ID: 18069285
[TBL] [Abstract][Full Text] [Related]
10. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
Franke A; Hepp C; Harder H; Beglinger C; Singer MV
Scand J Gastroenterol; 2008; 43(12):1425-31. PubMed ID: 18924018
[TBL] [Abstract][Full Text] [Related]
11. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors.
Scheiman JM; Yeomans ND; Talley NJ; Vakil N; Chan FK; Tulassay Z; Rainoldi JL; Szczepanski L; Ung KA; Kleczkowski D; Ahlbom H; Naesdal J; Hawkey C
Am J Gastroenterol; 2006 Apr; 101(4):701-10. PubMed ID: 16494585
[TBL] [Abstract][Full Text] [Related]
12. Rabeprazole for the treatment of acid-related disorders.
Marelli S; Pace F
Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):423-35. PubMed ID: 22928894
[TBL] [Abstract][Full Text] [Related]
13. Esomeprazole for asthma.
Hsu CS; Kao JH
N Engl J Med; 2009 Jul; 361(2):206; author reply 207-8. PubMed ID: 19587349
[No Abstract] [Full Text] [Related]
14. Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP; Wu TS; Dan YY
J Clin Pharm Ther; 2015 Aug; 40(4):368-75. PubMed ID: 25893507
[TBL] [Abstract][Full Text] [Related]
15. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients.
Tulassay Z; Stolte M; Sjölund M; Engstrand L; Butruk E; Malfertheiner P; Dite P; Tchernev K; Wong BC; Gottlow M; Eklund S; Wrangstadh M; Nagy P
Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):526-36. PubMed ID: 18467912
[TBL] [Abstract][Full Text] [Related]
16. Esomeprazole magnesium (Nexium).
Baker DE
Rev Gastroenterol Disord; 2001; 1(1):32-41. PubMed ID: 12120118
[TBL] [Abstract][Full Text] [Related]
17. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
Moayyedi P; Armstrong D; Hunt RH; Lei Y; Bukoski M; White RJ
Am J Gastroenterol; 2010 Nov; 105(11):2341-6. PubMed ID: 20842110
[TBL] [Abstract][Full Text] [Related]
18. The Australian rise of esomeprazole-was expenditure on samples a contributor?
Kyle GJ; Nissen LM; Tett SE
Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):62-8. PubMed ID: 19111014
[TBL] [Abstract][Full Text] [Related]
19. [Proton pump inhibitors, a family of drugs in continuous expansion].
Pellicano R
Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
[No Abstract] [Full Text] [Related]
20. Naproxen/esomeprazole (Vimovo).
Med Lett Drugs Ther; 2010 Sep; 52(1347):74-5. PubMed ID: 20847717
[No Abstract] [Full Text] [Related]
[Next] [New Search]